Hair Strengthening & Damage Repair: Keratin, Amino Acid & Bond-Building Technology

Overview #

Most hair damage briefs we receive start with the same request: “We want a bond repair claim.” What brand owners mean by that, and what the chemistry actually supports, are often two different things. Keratin, amino acids, and maleic acid–based bond builders each work through distinct mechanisms — and the clinical evidence behind them varies considerably. Before you lock in an on-pack claim, you need to understand what each active can actually prove, and in which regulatory market that proof holds up.

The Three Actives: What the Evidence Actually Shows #

Hydrolyzed Keratin

The most commonly cited study we reference in client briefs is a single-blind, controlled trial (n=40, 8 weeks) measuring tensile strength in chemically processed hair. Subjects used a shampoo and conditioner system containing 2% hydrolyzed keratin (MW <1000 Da). Tensile strength improved by 18% versus the untreated control group, and combing force was reduced by 23%. Those are real numbers. What the study doesn’t capture — and what we see in our own conditioning trials — is that the benefit is largely surface-adsorption. Wash it out enough times and the effect diminishes. Substantivity is the real formulation challenge, not the active itself.

We typically work with hydrolyzed keratin at 1–3% in rinse-off formats and 0.5–1.5% in leave-on serums. Below 1% in rinse-off, the sensory benefit is there but the structural claim gets harder to defend. Above 3%, you’re paying for ingredient cost without proportional performance gain. Honestly, most brands push for higher percentages thinking more is better. It rarely is with film-forming proteins.

Amino Acid Complexes (Arginine, Cystine, Glutamic Acid)

This is where the evidence gets more interesting. A double-blind, randomized controlled trial (n=60, 12 weeks) evaluated a leave-on treatment containing a blend of arginine (0.5%), cystine (0.3%), and glutamic acid (0.2%) against a placebo. Hair breakage — measured by fiber count in a standardized combing test — was reduced by 34% in the active group. Elasticity recovery (measured post-stretch) improved by 19%. The study design was solid. What it doesn’t tell you is whether the blend drives the result or whether arginine alone is doing most of the work. We’ve run internal split tests and our read is that arginine is the primary driver in that combination.

Cystine is worth a separate note. It’s the oxidized dimer of cysteine, and it can participate in disulfide bond reformation under the right conditions — but “the right conditions” in a cosmetic rinse-off format are hard to guarantee. We’re still not fully convinced the disulfide reformation story holds at the concentrations and contact times typical of a shampoo. Leave-on formats are a different conversation.

Maleic Acid Bond Builders

The bond-building category was essentially created by one ingredient platform, and the clinical data behind it is more robust than most actives in this space. A randomized, evaluator-blind study (n=48, single treatment session) measured fiber integrity in bleached hair using scanning electron microscopy and tensile testing. A maleic acid–based treatment at 4.5% (pH 4.5–5.0) showed a 40% reduction in breakage versus untreated bleached hair, with cuticle smoothness scores improving by 2.1 points on a 5-point scale. Single-session results. That’s the claim story brands want.

The formulation constraint nobody talks about upfront: maleic acid systems are pH-sensitive in a way that creates real manufacturing headaches. You need to hold pH between 4.2 and 5.2 for the chemistry to work. Drift above 5.5 and you lose efficacy. Drift below 4.0 and you’re in scalp irritation territory. On our production line, we’ve seen batch-to-batch pH variance of ±0.3 units when the neutralization step isn’t tightly controlled. At lab scale that’s manageable. At 500 kg batches, it requires inline pH monitoring and a tighter raw material spec on the maleic acid itself. One pilot batch failed because the supplier changed their maleic acid grade mid-project and the buffering behavior shifted. We now require certificate of analysis pH profiling from all maleic acid suppliers before we accept a new lot.

Evidence Strength Comparison #

Where Most Brands Get the Claim Wrong #

“Bond repair” is not a cosmetic claim in the EU. It’s not a drug claim either — it sits in a grey zone that EU Cosmetics Regulation 1223/2009 doesn’t explicitly address, which means it gets evaluated case by case by national competent authorities. What we tell brand partners is this: if you want to use “bond repair” in the EU, you need a consumer perception study or an instrumental study that demonstrates the claim is not misleading. The SCCS Scientific Opinion framework on claim substantiation is the reference point here, even though it’s not legally binding in the same way as the Annex restrictions.

In the US, the FDA Cosmetics Guidelines position is cleaner in one sense: cosmetic claims can’t imply drug action, so “repairs broken bonds” is riskier than “helps strengthen hair against breakage.” The distinction sounds semantic. It isn’t. One implies a structural change to the hair fiber (drug territory), the other describes a functional benefit observable by the consumer (cosmetic territory). We almost always push back on briefs that use “repair” as the primary claim verb without a substantiation package behind it.

NMPA is a different story. Under NMPA Cosmetic Regulation, hair care products with strengthening claims fall under general cosmetics, but the claim language must match the registered product function category. “Repair” as a standalone claim has been flagged in several registration reviews we’ve supported. “Nourishing” and “conditioning” are safer functional categories for the Chinese market, with strengthening framed as a secondary benefit.

A lot of brands underestimate how much the claim drives the formulation brief — not the other way around. If you know you’re launching in the EU first, we design the substantiation package before we finalize the formula. That’s not how most brands think about it, but it’s the right sequence.

The Hard Truth About Scale-Up #

Worked fine at 500 g lab scale. At 200 kg production, we saw viscosity drift in a keratin-amino acid serum that took three batches to diagnose. The culprit was shear rate during the mixing phase — the high-shear homogenizer we use at production scale was partially denaturing the hydrolyzed keratin, reducing its film-forming capacity and changing the rheology profile. The fix was straightforward once we identified it: switch to a low-shear paddle mixer for the protein addition step and add the keratin fraction post-homogenization. But it cost us two weeks and two failed batches to get there.

The maleic acid systems have their own scale-up issue. At lab scale, you can hand-mix and check pH every 30 seconds. On the production line, the neutralization happens in a 300-liter vessel with a fixed agitation speed. If the caustic addition rate isn’t calibrated precisely, you overshoot pH and the batch is out of spec. We’ve seen this happen. The solution is a semi-automated dosing system with inline pH feedback, which adds equipment cost that not every contract manufacturer has. Worth asking your OEM partner directly whether they have it.

For brands considering encapsulation technology for amino acid delivery — which does improve penetration and substantivity — the scale-up complexity increases again. Encapsulated actives behave differently under shear, and the encapsulation integrity needs to be verified post-manufacturing, not just post-lab. It’s not a perfect solution.

Claim Substantiation Guidance by Market #

This is the section most brand owners skip until they’re six weeks from launch. Don’t do that.

EU: Claim substantiation under the EU framework requires evidence that is “truthful, evidenced, honest, fair, informed and not misleading” — those are the six criteria from the Common Criteria regulation (EC 655/2013). For a “strengthens hair” claim, you need at minimum one instrumental study (tensile testing, combing force, or fiber breakage count) conducted on the finished product, not the raw material. Supplier data alone is not sufficient. The study should reflect the actual use conditions — rinse-off contact time, application method, water hardness if relevant. We’ve had claims challenged because the supporting study used distilled water and the product is sold in markets with hard water. Details matter.

US: The FDA doesn’t require pre-market substantiation submission for cosmetics, but the brand is responsible for having “competent and reliable scientific evidence” on file before making a claim. For hair strengthening, that typically means a consumer use study (n≥30, minimum 4 weeks) or an instrumental study. The ICH Stability Guidelines framework isn’t directly applicable to cosmetics, but the stability data principles — accelerated testing at 40°C/75% RH, real-time at 25°C/60% RH — are what we follow for finished product stability packages that support US market submissions.

NMPA: For general cosmetics registration in China, the claim must align with the declared function category. Strengthening and anti-breakage claims are supportable under the “hair care” function category, but you’ll need a safety assessment and, for some claim types, efficacy testing conducted by a NMPA-recognized testing institution. This is the part that adds 3–4 months to a China launch timeline if you haven’t planned for it. We support clients through this process, but the testing institution relationship is something you need to establish early. See our scalp and hair growth formulation resources for more on how we structure China-market hair care development.

Formulation Notes for Brand Partners #

What market? What are you expecting on-pack? Those are the first two questions we ask on every hair repair brief, because the answers determine everything from active selection to pH target to packaging format.

If you’re targeting EU with a “strengthens against breakage” claim, we’ll build the formula around a leave-on format — amino acid complex at 0.8–1.2% total, hydrolyzed keratin at 1% for sensory, and a substantivity agent (typically a cationic polymer at 0.3–0.5%) to extend the benefit through multiple washes. We’ll run a combing force study on the finished product before you lock the claim.

If you want a bond-building treatment for salon or professional use, maleic acid at 4–5% in a two-step system is the right architecture. Step 1 is the active treatment (pH 4.5), Step 2 is a conditioning sealant (pH 5.5–6.0). The two-step format also gives you a stronger claim story because you can demonstrate the pH-dependent mechanism in your substantiation package.

MOQ and cost reality: a leave-on amino acid serum at this specification runs roughly $4.50–$7.00 per unit at MOQ 3,000 units depending on packaging. A maleic acid two-step system is higher — typically $8–$12 per unit at the same MOQ — because the active cost and the two-SKU format both add up. Airless pump packaging, which we recommend for the leave-on serum to prevent oxidation of the amino acid fraction, adds $0.50–$0.80 per unit on top of that. Most indie brands can absorb it. Some can’t, and we’ll tell you that upfront rather than let you find out at the proforma stage.

Frequently Asked Questions #

Q: Can we just use “bond repair” on pack for the US market?

Technically you can, but we’d advise against it without a substantiation package. The FDA’s position is that claims implying structural repair to the hair fiber can edge toward drug territory. “Helps strengthen hair against breakage” is a safer claim architecture and easier to substantiate with a standard combing force study. If “bond repair” is non-negotiable for your brand, we can build a study design around it — but budget 8–12 weeks for the consumer use study.

Q: We’ve seen keratin percentages as high as 10% on competitor labels — should we match that?

Honestly, no. Above 3% in a rinse-off format, you’re not getting proportional performance gain — you’re paying for label marketing. Our internal dose-response work shows the sensory and tensile benefit plateaus around 2–3% for hydrolyzed keratin under 1000 Da. Higher MW fractions behave differently, but they also cost more and have worse rinse-off substantivity. The 10% figure on a competitor label is almost certainly a marketing decision, not a formulation one.

Q: How do we know the maleic acid bond-building chemistry is actually working in our finished formula?

You verify it with a fiber breakage test on the finished product — not on the raw material, not on a model system. We run a standardized combing test (50 strokes, pre-damaged hair, wet condition) and count fiber breaks versus an untreated control. A well-formulated maleic acid system at 4–5% should show at least 30–40% breakage reduction. If you’re not seeing that, the pH is probably off or the active concentration dropped during manufacturing.

Q: Can we combine keratin and maleic acid in the same formula?

You can, but it requires careful sequencing. Maleic acid at pH 4.2–5.2 can interact with the cationic sites on hydrolyzed keratin and affect deposition. In our experience, the combination works better in a two-step system than in a single formula. If a single-formula brief is a hard requirement, we’d cap the keratin at 1% and keep the maleic acid at 3% maximum, with the pH held at 4.8. It’s not a perfect solution.

Q: For NMPA registration, do we need Chinese-market clinical data or can we use our existing EU study?

For general cosmetics, NMPA accepts foreign study data in principle, but the testing institution needs to meet NMPA recognition criteria, and the study protocol needs to align with Chinese testing standards. In practice, most EU-conducted studies don’t map cleanly onto NMPA requirements without supplementary data. Budget for at least one China-side efficacy test — typically 4–6 weeks at a recognized institution — even if you have strong EU data. We’ve seen brands try to skip this step and lose 3 months at the registration review stage.

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.